You are about to leave jnjmedtech.com. By clicking to continue, you will be taken to a web site governed by their own Legal and Privacy Policies.
About Biosense Webster in Canada
We are dedicated to advancing AF treatment through focusing on three main areas: innovating new technology solutions, investing in research and publications to advance clinical understanding, and improving education and awareness of AF among clinicians and the general public.
Advanced 3D mapping, data integration, and technical innovation defines a range of instruments created for the treatment of cardiac arrythmias.
Clinical research and evidence from the field of electrophysiology, cardiac arrythmias, and atrial fibrillation.
©2022 Johnson & Johnson Medical Products, a Division of Johnson & Johnson Inc. All rights reserved. CAN 202187-220126